Preoperative IMRT With Concurrent Anlotinib for Localised Extremity or Trunk Sarcoma （SPARE-01）

NCT05167994 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Sarcoma,Soft Tissue
Extremity
Trunk
Anlotinib
Intensity-modulated Radiotherapy
Major Wound Complications

Interventions

DRUG: Anlotinib hydrochloride

Sponsor

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Collaborators

[object Object]